Introduction
The acquired immunodeficiency syndrome (AIDS) is a pandemic immunosuppressive disease caused by the depletion of CD4 positive lymphocytes (CD4+ T-cells). The causative agent of AIDS is the human immunodeficiency virus type 1 (HIV-1) (Barre-Sinoussi et al., 1983) .
SUlfated polysaccharides such as heparin and dextran sulfate are potent inhibitors of the replication of HIV-1 in vitro (Ito et si., 1987) . Their mechanism of action has been associated with their capacity to block the adsorption of HIV virions to the CD4+T-cell membrane (Saba et al., 1988a,b; Mitsuya et al., 1988; Nakashima et al., 1989; Schols et a/., 1989a) . They specifically interact with the viral gp120 glycoprotein and inhibit HIV-induced syncytium formation (Saba et al., 1990) , which is assumed to play an important role in the depletion of CD4+T-Iymphocytes in AIDS patients (Haseltine, 1988) . Sulfated polysaccharides, and polysulfates in general, are inhibitory not only to HIV but also to other enveloped viruses including herpes simplex virus, cytomegalovirus, influenza A virus, vesicular stomatitis virus, respiratory syncytial virus and various toga-, arena-and retroviruses (Saba et al., 1988c; Schols et a/., 1990a; Witvrouw et al., 1991 Witvrouw et al., ,1992 .
We have initiated an investigation of the antiviral activity of Venezuelan medicinal plants. Extracts from a diverse group of plant families have been tested against HIV-1 in vitro (Chang and Yeung, 1988) , and some extracts, namely these from Arctium lappa L., Viola yedoensis and Prunella vUlgaris, were shown to demonstrate anti-HIV activity (Tan et a/., 1991) . Also, natural substances such as lignin and tannin were found to inhibit HIV replication (Unten et al., 1991) . Anti-HIV activity has also been reported for a series of natural polysaccharides extracted from various sources (Nakashima et al., 1987; Hirabayashi et a/., 1989) .
The present study deals with the antiviral properties of GS, a galactan sulfate extracted from the red seaweed Aghardhiella tenera, its activity spectrum and its mechanism of antiviral action.
Results

Anti-HIVactivity
When GS was examined for its inhibitory effect on the cytopathic effect of HIV-1 (HTLV-III B ) and HIV-2 (LAV-2 RO D ) (Table 1) , the compound was found to provide protection at a concentration to-told higher than the concentration at which dextran sulfate (DS) protected the cells (50% inhibitory concentration: approximately 0.5 and 0.05 Table 2 . Inhibitory effects of GS. ATA and OS on the binding of HIV-1to Our studies indicate that GS, like other sulfated polysaccharides (e.g. dextran sulfate) (Baba et al., 1988c;  The inhibitory effect on the binding of HIV-1 to MT-4 cells was determined using a p24 ELISA assay, as described in 'Materials and Experimental procedures' . of anti-gp120 mAb (recognizing the V3 region of gp120) to persistently HIV-1-infected HUT-78 cells, all three compounds were found to inhibit the binding of anti-gp120 (Table 4) . At a concentration of 25fl9ml-1, GS, ATA and OS inhibited anti-gp120 mAb binding by 96,100 and 84%, respectively.
Discussion
Activity against DNA and RNA viruses other than HIV
When GS was examined for its inhibitory effect on the replication of ONA viruses, it proved markedly inhibitory to HSV-1, HSV-2, TK-HSV-1, GMV and VV (Table 5 ). The IG sc of GS for HSV-1 and VV was 3-to 30-fold lower than the IG so of ATA and OS for these viruses. When GS was examined for its inhibitory effect on the replication of RNA viruses other than HlV-1 or HIV-2 (Table 5) , the compound was found to be particularly active against Sindbis virus, influenza virus A, RSV and VSV. GS inhibited these viruses at a concentration that was equal to or lower than the concentration at which OS or ATA inhibited these viruses. None of GS, ATA and OS was active against influenza virus B, poliovirus-1, Goxsackie-B4 virus, reovirus-1 or arenaviruses (Junin, Tacaribe) at concentrations that were significantly lower than the cytotoxicity threshold. GS did not cause a microscopically detectable change in the morphology of HeLa or MOGK cells at concentrations up to 400 fl9 mr'. The concentration required to cause an alteration of E 6SM, Vero and HEL cell morphology was :2:100 fl9 ml" .
Cytotoxicity Compounds
HIV-1 HIV-2 CC 5 0 b (pg mr") GS 0.6 ± 0.4 0.5± 0.3 >250 ATA 0.2± 0.03 0.8±0.5 >250 OS 0.05± 0.02 0.04± 0.02 >250 fl9 ml-1 , respectively). The protective activity shown by GS against HIV-1/HIV-2 was comparable to that of aurintricarboxylic acid (ATA) ( Table 1) . GS suppressed syncytium (giant cell) formation (induced by either HIV-1 or HIV-2) at concentrations higher than 5 fl9 mr". None of GS, ATA and OS reduced the viability of mock-infected MT-4 cells, as monitored by the MTI method (Pauwels et al., 1988) at concentrations up to 250 fl9 rnr' (Table 1) .
a50% inhibitory concentration, based on the inhibition of HIV-induced cytopathic effect in MT-4 cells. b50% Cytotoxic concentration, based on the reduction of viability of mock-infected MT-4 cells.
Virus cytopathicity IC 5 0 a (pg ml-1) 
Mechanism of anti-HIV activity
Using a p24 ELISA assay, we demonstrated that GS blocks the binding of HIV-1 to the MT-4 cells (50% inhibitory concentration: approximately 40 fl9 mr"), Following the same procedures, we found that ATA (50% inhibitory concentration: 2fl9 mr') and OS (50% inhibitory concentration: <0.2fl9 ml') achieved a 20-to at least 200-fold stronger inhibition of virus-cell binding than did GS (Table 2 ). This confirms previous results obtained for OS and ATA by a flow cytometric (FAGS) method (Schols et el., 1989a) . When GS, ATA and OS were evaluated for their ability to inhibit the binding of OKT4A mAb to the G04 receptor of MT-4 cells (which are OKT4A+ for more than 99%), GS and OS were found not to influence the binding of OKT4A mAb, even at concentrations that were higher than those required for complete protection of MT-4 cells against HIV-1 cytopathic effect (Table 3 ). In contrast, ATA effected a marked, concentration-dependent reduction of OKT4A mAb binding: Le. at a concentration of 25 fl9 mr', ATA achieved a 90"/0 inhibition of OKT4A staining by mAb, even if the cells had been in contact with the compound for only 10-20 s (Table 3) .
Aurintricarboxylic acid and dextran sulfate have been shown previously to interact directly with the HIV envelope glycoprotein gp120 (Schols et al., 1990b) . The viral gp120 is involved in both virus-cell binding and giant cell formation (Skinner et al., 1988) . When GS, ATA and OS were examined for their ability to interfere with the binding Antiviral activity of a seaweed-derived sulfated galactan 299 cells (Table 2 ). The relative potencies of GS, ATA and OS in achieving 50% inhibition of virus binding correspond to their relative potencies in inhibiting HIV-1 cytopathic effect in MT-4 cells; namely, GS is effective at an approximately 5-to 10-fold higher concentration than is ATA or OS. The inhibition of virus binding by GS can be ascribed to a direct interaction of the compound with the HIV envelope glycoprotein (gp120) ( Table 4 ). Pretrea.tment of the HIV particles for 1 h at 3loC with GS did not influence the cytopathic effect of HIV (data not shown). The inhibitory effects of GS on enveloped viruses other than HIV, such as HSV, RSV, VSV and influenza A virus, may also be attributed to inhibition of virus binding to the host cells. Seaweeds are a rich source of proteins in the diet of oriental people. Few side-effects and a low cost price may be expected for antiviral agents extracted from natural sources. In this respect, the identification in red seaweed of a component with anti-HIV and -HSV activity may be of particular importance. Whether GS has any clinical potential, i.e. in the systemic and/or topical therapy or prophylaxis of HIV or HSV infections, remains to be determined.
In conclusion, our results suggest that a natural polysaccharide product is a potent inhibitor of HIV and HIV-1-infected HUT-78 cells [200000 cells (100/11-1) RPM I without serum] were washed twice, incubated with the compounds at the indicated concentrations at 20°C for 20 min, stained and analysed as described in 'Materials and Experimental procedures'. The inhibitory index for anti-gp120 mAb binding inhibition (lIgp120) was calculated according to the formula IIgp120 = 1 -(MFgp120X -MFdMFgp120 -MFcl, where MFgp120 is the mean channel fluorescence (MF) for the cells incubated with anti-gp120 mAb at concentration X, MFgp120X is the MF for the cells incubated with test compound and anti-gp120 mAb, and MF c is the MF of the cells incubated with RaM-lgG-F(ab'j,-FITC to determine nonspecific fluorescence. MF was determined by the Consort 30 program (Becton-Dickinson). et al., 1991) and sulfated polymers (e.g. polyvinylalcohol sulfate and polyacetal polysulfate) (Schols et al., 1990a; Witvrouw et al., 1992) , has a broadspectrum antiviral activity against a variety of enveloped viruses (Tables 1 and 5 ). GS is particularly active against HIV and HSV. It inhibits the replication of these viruses at a concentration of about 0.5-1.0,ug mr'. GS is not inhibitory to MT-4 and EeSM cell proliferation at concentrations up to 250 and 100,ug mr', respectively. Thus the selectivity index of GS for HIV (in MT-4 cells) and HSV (in EeSM cells) can be estimated to be >350 and >150, respectively. The marked activity of GS against both HIV and HSV may be of particular utility in AIDS patients where recurrent HSV infections may often complicate and even enhance the underlying HIV disease (Tremblay et al.,1989) .
RaM
The antiviral activity spectrum of GS is somewhat different from that of dextran sulfate, in that this compound is more active than dextran sulfate against parainfluenza virus type 3, Semliki forest Virus, Sindbis virus, influenza A virus, RSV, VV and HSV-1, but less active against HIV-1, HIV-2 and CMV. In fact, the activity spectrum of GS is comparable to that of ATA.
The mechanism of the anti-HIV action of GS may be attributed to the inhibition of the binding of virus to the The product was recovered on a Buchner filter and treated again three times, using a fresh solution each time, before it was redissolved in water; the solution was clarified by filtration, and the polysaccharide was reprecipitated with propan-z-ol as before. Finally, the polysaccharide was washed repeatedly with water-propan-z-ol (three times in 60% v/v and twice in 90% v/v) until the washing gave a negative test for chloride, then dried at 60°C and ground to powder. The sulphate content was measured according to the procedure described by Therno (1971) . The sulphate content was 28% of dry weight.
Cells
MT-4 cells (Miyoshi et al., 1982) and MOLT-4 cells (clone 8) (Kikukawa et al., 1986) were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, 0.1% sodium bicarbonate and 20,ug rnl" gentamicin. All other cell cultures [Vero, HeLa, EsSM and MOCK (Madin-Darby canine kidney)], except for HEL cells, were maintained in Eagle'S minimum essential medium (MEM) supplemented with 10% FCS, 2mM L-glutamine and 0.1% sodium bicarbonate. HEL (human embryonic lung) fibroblasts cells were kept in MEM supplemented with 10% FCS, 2 mM Lglutamine and 0.02% sodium bicarbonate. HSV infections in vitro. The in vivo efficacy and bioavailability of GS, and its toxicity profile upon both systemic and topical administration, are subjects for further study.
Materials and Experimental procedures
Compounds
Dextran sulfate (OS) (MW 5000) was purchased from the Sigma Chemical Co. (St Louis, MO, USA). Aurintricarboxylic acid (ATA) (MW 422.35) was obtained from the Aldrich Chemical Co. (Brussels, Belgium) . GS, a galactan sulfate (DiNinno and McCandless, 1978; Taylor and Buchanan-Smith, 1992) , was isolated by Dr Natale Villori Bianchini (Biotecnologfa Epsilon CA, Caracas, Venezuela).
The polysaccharide was extracted and purified from the Venezuelan red seaweed Agardhiella tenere, isolated from the Mochima National Park on the eastern coast of Venzuela. After harvesting, the alga was air-dried for transport to the laboratory, then washed in cold running water (30 min), drained, and heated (2 h) in boiling water, before blending (Waring Blender) and further heating (2 h). After filtration, the polysaccharide was precipitated by addition of propan-z-ol (2-3 volumes), washed (2 volumes, 90% vlv water-propan-z-ol), dried at 60°C, pulverized, and converted into the potassium salt by stirring the recovered powder at 25°C for 12 h in 25 parts by weight of watsr-propan-z-ol (50% v/v) containing 14% by weight of potassium chloride.
Viruses
The virus stocks were prepared as described previously: herpes simplex virus type 1 (HSV-1) (strain KOS), HSV-2 (strain G), thymidine kinase-deficient (TK-) HSV-1 (strain B2006) (De Clercq et al., 1980) , TK-HSV-1 (strain VMW-1837) (Vinckier et al., 1987) , vaccinia virus (VV), vesicular stomatitis virus (VSV), Coxsackie virus type B4, poliovirus type 1 and Sindbis virus (De Clercq et al., 1975) ; influenza virus A (strain AIIshikawa/7/82 H3N2); influenza virus B (strain B/Singapore/222179) (Shigeta et al., 1988) ; respiratory syncytial virus (RSV) (strain Long) (Kawana et al., 1987) ; human immunodeficiency virus type 1 (HIV-1) (strain HTLV-IIIs/LAI) (Popovic et al., 1984) , HIV-2 (strain LAV-2 Ro D ) (Clavel et al., 1986) , as obtained from the culture supernatant of HIV-1-or HIV-2infected cell lines (HUT-78/HTLV-llI s, MT-4/LAV-2 Ro D , respectively) Schols et al., 1989b) ; parainfluenza virus type 3 (ATCC VR-93), reovirus type 1 (ATCC VR-230), cytomegalovirus (CMV) [strain Davis (ATCC VR-807)], Semliki forest virus (ATCC VR-67), as obtained from the American Type Culture Collection (Rockville, MD, USA). Junin virus and Tacaribe virus were provided by Dr C.E. Coto (Buenos Aires, Argentina).
Antiviral activity assays
For HSV, VV, VSV, Coxsackie, polio, parainfluenza, Sindbis, Semliki forest, Junin, Tacaribe and reovirus, the assay procedures have been described previously (De Clercq at al., 1975 , 1980 Andrei and De Clercq, 1990) . Confluent (Vero, HeLa or EsSM) cell cultures in 96-well microtitre trays were exposed to 100 CCID so (1 CCID so being the infective dose for 50% of the cell CUltures) of virus per well in the presence of varying concentrations of the test compounds diluted in Eagle's minimum essential medium (MEM) supplemented with 3% FCS, 2 mM L-glutamine and 0.1% sodium bicarbonate. The cells were further incubated at 37 DC until virus-induced cytopathic effect was completed in the control (virus-infected untreated) cell cultures.
The inhibitory effects of the test compounds on HIV-1 and HIV-2 replication were monitored by the inhibition of virusinduced cytopathic effect in MT-4 cells. Briefly, MT-4 cells were suspended at 3 x 10 5 cells mr' and infected with HIV-1 or HIV-2 at 100 CCID 5 0 rnr". Immediately after infection, 100 pi of the cell suspension was brought into each well of a flat-bottomed microtitre tray containing various concentrations of the test compounds. After 5 days incubation at 37 DC, the number of viable cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method, as previously described (Pauwels et a/., 1988) .
For influenza virus and RSV, confluent cell cultures (MOCK and HeLa, respectively) in microtitre trays were inoculated with 20 CCID 5 0 of the virus per well. The cells were further incubated in the presence of various concentrations of the test compounds and monitored for virus-induced cytopathic effect as described previously (Kawana et a/., 1987; Shigeta et a/., 1988) .
1F
or the anti-CMV assays, huma~mbryonic lung (HEL) fibroblasts were infected with 100 plaqfie forming units (pfu) of virus. Compounds and virus were added simultaneously, and the cells were further incubated at 37 DC in MEM supplemented with 2% FCS, 2 mM L-glutamine and 0.02% sodium bicarbonate. Virus plaque formation was monitored as described previously (Snoeck et a/., 1988) .
Virus-induced cytopathic effect was recorded at 1 or 2 days post-infection p.i. for VSV; at 2 days p.i. for Coxsackie virus, Semliki forest virus and poliovirus; at 2 or 3 days p.i. for HSV-1 (KOS), HSV-2 (G), TK-HSV-1 (VMW-1837 and B2006), VV and Sindbis virus; at 3 days p.i. for influenza A and B viruses and respiratory syncytial virus; at 4 to 5 days p.i. for parainfluenza virus; at 5 days p.l. for Junin virus, Tacaribe virus, HIV-1 and HIV-2; and at 6 to 7 days p.i. for CMV and reovirus.
Giant cell syncytium formation
MOLT-4 (clone 8) cells (1.8 x 10 6 cells mr') were cultured with persistently HIV-1-or HIV-2-infected HUT-78 cells (2 x 10 5 cells ml-1 ) in microtitre tray wells containing various concentrations of the test compounds. After a 24-h cocultivation period, the number of giant cells (syncytia) was recorded microscopically, as described previouly (Baba et a/., 1990) .
Virus adsorption assay
The inhibitory effects of the test compounds on virus adsorption were measured in parallel using two techniques. First, an indirect immunofluorescence-laser flow cytofluorographic method has been specifically designed for this purpose (Schols et a/., 1989a) . Briefly, MT-4 cells were exposed to HIV-1 virions, which had been concentrated from the supernatant of HIV-1-infected MT-4 cells in the presence or absence of the test compounds. The compounds were added 10-20 s before the virus was added. The cells were processed for indirect immunofluorescence using a polyclonal antibody to HIV-1, and Antiviral activity of a seaweed-derived sulfated galactan 301 analysed for cell-bound HIV-1 virions by laser flow cytofluorography. In a second assay, MT-4 cells (5 x 10 5 cells per tube) were incubated with HIV-1 (corresponding to 100 ng of p24) in the presence or absence of the test compound. After a 2-h incubation period at 37 DC, cells were extensively washed with phosphate buffered saline (PBS) to remove unadsorbed virus particles. The cells were then lysed with PBS containing 0.5% Nonidet-P40. The amount of antigen was determined by an enzyme-linked immunosorbent assay (ELISA) (DuPont).
CD4 immunofluorescence assay
CD4 expression was determined by FACSTAR (Becton-Dickinson, Erembodegem, Belgium) analysis, as described previously (Schols et a/., 1989b) . Briefly, MT-4 cells were incubated for 10-20 s at room temperature in PBS in the absence of serum with or without test compound. The cells were then stained with optimal concentrations of the monoclonal antibodies OKT4A-FITC (Ortho Diagnostics) and Simultest immune monitoring kit control [FITC-Iabelled IgG 1-Phycoerythrin (PE)-Iabelled IgG 2al (Becton-Dickinson) for 20 min at 4 DC, washed once in PBS, and fixed in 0.5 ml of 0.5% paraformaldehyde in PBS.
Glycoprotein gp120 immunofluorescence assay
Normal HUT-78 and HIV-1-infected HUT-78 (HUT-78/HIV-1) cells were grown in RPMI1640 supplemented with 10% heatinactivated FCS, 100 IU rnr' of penicillin G, and 20 pg mr" of gentamicin. HUT-78/HIV-1 cells (200000 cells) in 100pl of RPMI with 10% FCS were washed twice in RPMI with 10% FCS, incubated with the compounds at various concentrations at 20 DC for 15-20 min in RPMI, washed twice with RPMI to remove residual compound, stained with antl-qptzo mAb (9284, DuPont de Nemours, Brussels, Belgium) for 50 min at 37 DC, washed twice in PBS, incubated with FITC-conjugated F(ab'b fragments of rabbit anti-mouse immunoglobulin antibody [RaM-lgG-F(ab'kFITCl (Prosan, Ghent, Belgium) for 50 min at 37 DC, washed once in PBS, resuspended in 0.5 ml of 0.5% paraformaldehyde in PBS, and analysed by flow cytometry as described previously (Schols et a/., 1990b) . The threshold of positivity for green fluorescence intensity was arbitrarily established on the basis of HIV-1-infected HUT-78 cells incubated solely with RaM-lgG-F(ab'kFITC.
